Roles of intralesional bacteria in the initiation and progression of oral squamous cell carcinoma

被引:0
作者
Luo, Zhuoyan [1 ,2 ]
Lv, Shiping [1 ,2 ]
Lou, Fangzhi [1 ,2 ]
Yan, Li [3 ]
Xu, Jingyi [1 ,2 ]
Kang, Ning [1 ,2 ]
Dong, Yunmei [1 ,2 ]
Jin, Xin [1 ,2 ]
机构
[1] Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China
[2] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China
[3] Chongqing Med Univ, Coll Med Informat, Chongqing, Peoples R China
来源
CANCER MEDICINE | 2024年 / 13卷 / 18期
关键词
intralesional bacteria; microenvironment; oral microbiota; oral potentially malignant disorders; oral squamous cell carcinoma; PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; GENE-EXPRESSION; CANCER; TUMOR; PROLIFERATION; MICROBIOME; INDUCTION; CARCINOGENESIS; RESISTANCE;
D O I
10.1002/cam4.70209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Oral squamous cell carcinoma (OSCC) is the predominant form of head and neck cancer, often diagnosed at late stages, resulting in a poor prognosis. Recent studies indicate a potential association between OSCC and microbial presence. Microorganisms have been identified in various tumors and lesions, including OSCC and oral potentially malignant disorders (OPMDs). Intralesional microbiota are considered important components of the tumor microenvironment (TME) and may contribute to carcinogenesis. Methods: Sources were collected through thorough searches of databases PubMed and Embase. The review focused on microbial characteristics, potential origins, and their impact on cancer progression. Results: Bacteria display varying abundance and diversity throughout the stages of OSCC and OPMDs. Intraleisional bacteria may have diverse sources, including not only oral plaque and saliva but also potentially the gut. Intralesional bacteria have both pro- carcinogenic and anti- carcinogenic effects, affecting processes like cell proliferation, invasion, and immune response. Conclusions: Intralesional microbiota are crucial in OSCC and OPMDs, influencing both disease progression and treatments. Despite their significance, challenges like inconsistent sampling and microbial identification remain. Future research is required to fully understand their role and improve clinical applications.
引用
收藏
页数:19
相关论文
共 118 条
  • [21] Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells
    Geng, Fengxue
    Zhang, Yunjia
    Lu, Ze
    Zhang, Shuwei
    Pan, Yaping
    [J]. DNA AND CELL BIOLOGY, 2020, 39 (01) : 144 - 151
  • [22] Cleavage of protease-activated receptors on an immortalized oral epithelial cell line by Porphyromonas gingivalis gingipains
    Giacaman, Rodrigo A.
    Asrani, Anil C.
    Ross, Karen F.
    Herzberg, Mark C.
    [J]. MICROBIOLOGY-SGM, 2009, 155 : 3238 - 3246
  • [23] Differences in the bacteriome of swab, saliva, and tissue biopsies in oral cancer
    Gopinath, Divya
    Menon, Rohit Kunnath
    Wie, Chong Chun
    Banerjee, Moinak
    Panda, Swagatika
    Mandal, Deviprasad
    Behera, Paresh Kumar
    Roychoudhury, Susanta
    Kheur, Supriya
    Botelho, Michael George
    Johnson, Newell W.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism
    Groeger, S.
    Denter, F.
    Lochnit, G.
    Schmitz, M. L.
    Meyle, J.
    [J]. INFECTION AND IMMUNITY, 2020, 88 (05)
  • [25] Porphyromonas gingivalis W83 Membrane Components Induce Distinct Profiles of Metabolic Genes in Oral Squamous Carcinoma Cells
    Groeger, Sabine
    Herrmann, Jens Martin
    Chakraborty, Trinad
    Domann, Eugen
    Ruf, Sabine
    Meyle, Joerg
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [26] Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells
    Groeger, Sabine
    Jarzina, Fabian
    Domann, Eugen
    Meyle, Joerg
    [J]. BMC IMMUNOLOGY, 2017, 18
  • [27] Porphyromonas gingivalispromotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment
    Guo, Zhi-chen
    Jing, Si-li
    Jumatai, Sakendeke
    Gong, Zhong-cheng
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1523 - 1539
  • [28] Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
    Gur, Chamutal
    Ibrahim, Yara
    Isaacson, Batya
    Yamin, Rachel
    Abed, Jawad
    Gamliel, Moriya
    Enk, Jonatan
    Bar-On, Yotam
    Stanietsky-Kaynan, Noah
    Coppenhagen-Glazer, Shunit
    Shussman, Noam
    Almogy, Gideon
    Cuapio, Angelica
    Hofer, Erhard
    Mevorach, Dror
    Tabib, Adi
    Ortenberg, Rona
    Markel, Gal
    Miklic, Karmela
    Jonjic, Stipan
    Brennan, Caitlin A.
    Garrett, Wendy S.
    Bachrach, Gilad
    Mandelboim, Ofer
    [J]. IMMUNITY, 2015, 42 (02) : 344 - 355
  • [29] Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties
    Ha, Na Hee
    Woo, Bok Hee
    Kim, Da Jeong
    Ha, Eun Sin
    Choi, Jeom Il
    Kim, Sung Jo
    Park, Bong Soo
    Lee, Ji Hye
    Park, Hae Ryoun
    [J]. TUMOR BIOLOGY, 2015, 36 (12) : 9947 - 9960
  • [30] Hallmarks of Cancer: New Dimensions
    Hanahan, Douglas
    [J]. CANCER DISCOVERY, 2022, 12 (01) : 31 - 46